ArticleFrontiers in pharmacology2026
Microglial metabolic reprogramming drives the therapeutic effects of bavachinin on brain network function and memory in Alzheimer's disease.
Yang Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.